Design of inhibitory peptide targeting Toxoplasma gondii RON4‐human β‐tubulin interactions by implementing structural bioinformatics methods

Abstract

Toxoplasma gondii an obligate intracellular parasite causes toxoplasmosis in homeothermic animals. Host invasion of this parasite is mediated by the formation of Moving Junction (MJ) complex which encompasses a network of microneme and Rhoptry Neck proteins (RONs) 2/4/5/8. Among these proteins, RON4 is the only cytosolic secretory protein that is considered as a crucial member, as it directly facilitates the motility of MJ complex by interacting with host tubulin. It is also prominently localized at the host-pathogen interface during the invasion, thus projecting it as a potential drug target. The structure of RON4 is yet to be crystallized. Hence, in this study, fold recognition and Free Energy Landscape sampling was performed to predict the plausible 3D structure of RON4. Further, its interacting pattern with the reported crystal structure of human tubulin was analyzed using molecular docking. Subsequently, a β-tubulin based inhibitory peptides were derived based on its interacting interface observed in RON4-β-tubulin docked complex. Following which, a stepwise validation of these peptides for various physico-chemical properties and its homology with antimicrobial peptides were also screened. The peptide (RT_pep) surpassing all these validation filters was modeled and its stability was analysed by Molecular Dynamics simulation. To validate further, the stable conformation of the RT_pep was docked to RON4. Finally, essential molecular dynamics simulation was conducted to determine the stability and atomic motions of native RON4 and also to decipher its association with β-tubulin and RT_pep. All these analyses cumulatively suggest the therapeutic potential of RT_pep in targeting toxoplasmosis.

Microsecond Simulation of the Proteoglycan-like Region of Carbonic Anhydrase IX and Design of Chemical Inhibitors Targeting pH Homeostasis in Cancer Cells

“…A particle mesh Ewald method was implemented to calculate long-range electrostatic interactions using a grid size of 10 × 10 × 10 (grid spacing of 1.0 Å) . Finally, the production run was performed for 1 ms time scale, and trajectories were analyzed for conformational landscape. − The XMGRACE software was used for generating the plots from final trajectory ().…”

An Ex Vivo Potency Assay to Assess Active Drug Levels of A Glp-1 Agonistic Peptide During Preclinical Safety Studies

“…This approach recently led to the identification of a peptide therapeutic lead, able to inhibit kinase receptors of Leishmania and Trypanosoma, that impaired growth of both parasites in vitro and in vivo without toxic effects [16]. In another work, 3D structure and molecular docking studies were implemented to design inhibitory peptides, targeting T. gondii RON4-human β-tubulin interactions, that were effective in preventing host invasion [17].…”

Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approach

“…Recent studies have demonstrated that the administration of bNAbs is effective in suppressing viremia (9) and protecting against lentiviral infection in animal models (10,11), thus providing valuable insights for the design of effective HIV-1 vaccines (12,13). Very recently, researchers have directed their attention towards the development of therapeutic proteins and peptides targeting HIV, due to their 1 https://www.unaids.org/en advantages such as specificity and selective nature of action as compared to drugs and antibodies (14)(15)(16). Enfuvirtide (also known as Fuzeon or T20), an FDA-approved peptide-based drug, prevents the completion of HIV fusion events and has been used in combination with other anti-retroviral drugs for treating HIV infection (17).…”